DaVita Inc. Profile Avatar - Palmy Investing

DaVita Inc.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatie…

Medical - Care Facilities
US, Denver [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 56% Somewhat Positive
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 33% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 14.05 37.87 33.20
Graham Fair Price 21.56 25.46 20.94
PEG -51.70 0.20 -0.41
Price/Book 45.78 13.07 8.96
Price/Cash Flow 63.76 -47.29 28.88
Prices/Earnings -19.64 12.62 15.71
Price/Sales 30.95 3.94 3.01
Price/FCF 63.76 -47.29 28.88
Naive Interpretation member
01 - Valuation · Somewhat Positive
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 25.09 0.32 0.26
Operating Margin 20.72 0.16 0.13
ROA 60.78 0.01 < 0.005
ROE 0.14 0.26 81.41
ROIC 0.03 0.03 -8.35
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.07 < 0.005 5530.21
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -0.17 0.18 3.65
EPS QOQ -0.38 0.63 66.39
FCF QOQ -0.37 -1.78 -374.96
Revenue QOQ < 0.005 -0.02 205.58
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 5.52 6.31 14.37
Days Sales Outstanding (DSO) 69.12 87.67 26.84
Inventory Turnover 16.31 14.26 -12.56
Debt/Capitalization 0.89 0.93 4.18
Quick Ratio 1.09 1.30 18.37
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 11.69 10.55 -9.74
Cash 5.27 4.05 -23.11
Capex -1.76 -1.38 21.64
Free Cash Flow 3.63 -2.91 -19.65
Revenue 34.82 34.98 0.48
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.19 1.43 20.08
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 17.58 18.45 4.94
Naive Interpretation Member
06 - Financial Health · Weak
End of DVA's Analysis
CIK: 927066 CUSIP: 23918K108 ISIN: US23918K1088 LEI: - UEI: -
Secondary Listings